[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI20075968A0 - Menetelmä immunomodulaattorihoitojen tehokkuuden tarkkailemiseksi - Google Patents

Menetelmä immunomodulaattorihoitojen tehokkuuden tarkkailemiseksi

Info

Publication number
FI20075968A0
FI20075968A0 FI20075968A FI20075968A FI20075968A0 FI 20075968 A0 FI20075968 A0 FI 20075968A0 FI 20075968 A FI20075968 A FI 20075968A FI 20075968 A FI20075968 A FI 20075968A FI 20075968 A0 FI20075968 A0 FI 20075968A0
Authority
FI
Finland
Prior art keywords
effectiveness
monitoring
immunomodulator
treatments
immunomodulator treatments
Prior art date
Application number
FI20075968A
Other languages
English (en)
Swedish (sv)
Inventor
Kaija-Leena Kolho
Outi Vaarala
Original Assignee
Licentia Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Oy filed Critical Licentia Oy
Priority to FI20075968A priority Critical patent/FI20075968A0/fi
Publication of FI20075968A0 publication Critical patent/FI20075968A0/fi
Priority to PCT/FI2008/050790 priority patent/WO2009083653A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI20075968A 2007-12-28 2007-12-28 Menetelmä immunomodulaattorihoitojen tehokkuuden tarkkailemiseksi FI20075968A0 (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20075968A FI20075968A0 (fi) 2007-12-28 2007-12-28 Menetelmä immunomodulaattorihoitojen tehokkuuden tarkkailemiseksi
PCT/FI2008/050790 WO2009083653A1 (en) 2007-12-28 2008-12-29 Method for monitoring efficiency of treatments with immunomodulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075968A FI20075968A0 (fi) 2007-12-28 2007-12-28 Menetelmä immunomodulaattorihoitojen tehokkuuden tarkkailemiseksi

Publications (1)

Publication Number Publication Date
FI20075968A0 true FI20075968A0 (fi) 2007-12-28

Family

ID=38951663

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075968A FI20075968A0 (fi) 2007-12-28 2007-12-28 Menetelmä immunomodulaattorihoitojen tehokkuuden tarkkailemiseksi

Country Status (2)

Country Link
FI (1) FI20075968A0 (fi)
WO (1) WO2009083653A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2734233B1 (en) * 2011-07-18 2017-11-01 Hitachi Chemical Co., Ltd. Methods of predicting host responsiveness to cancer immunotherapies by ex vivo induction of leukocyte-function-associated mrnas
JP6624704B2 (ja) 2015-08-31 2019-12-25 日立化成株式会社 尿路上皮疾患の評価のための分子法
CA3000569A1 (en) * 2015-09-30 2017-04-06 Nogra Pharma Limited Methods of using smad7 antisense oligonucleotides based on biomarker expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070029733A (ko) * 2004-06-04 2007-03-14 제넨테크, 인크. 다발성 경화증의 치료 방법
US20060275800A1 (en) * 2005-04-29 2006-12-07 Doecke Wolf D Process for characterization of the transactivation and transrepression activity of glucocorticoid receptor ligands in primary immune cells

Also Published As

Publication number Publication date
WO2009083653A1 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
FI20085047A0 (fi) Menetelmä tasajännitevälipiirin kondensaattorien kunnonvalvontaan
FI20061090A (fi) Kunnonvalvontamenetelmä
BRPI0810228A2 (pt) Sistema e método para monitorar a condição física de equipamentos de poços de produção e controlar a produção de poços
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
FI20060277A (fi) Kunnonvalvontajärjestelmä
DE602006018197D1 (de) Ntsprechendes verfahren zum verfolgen der präsenz
DE602007003865D1 (de) Anlagenüberwachungssystem
SE0702104L (sv) Förfarande för behandling av avfall
FI20095928A0 (fi) Laite, järjestelmä ja menetelmä sähkölinjojen ja vastaavien kunnonvalvontaa varten
DE602006010449D1 (de) Behandlung von geflügel zwecks reduzierung der futon ascites
FI20070243A (fi) Menetelmä ja laitteisto sähkökoneiden kunnon seuraamiseksi
DE602007006562D1 (de) Reifenüberwachungssystem
BRPI0916818A2 (pt) Método para tratamento de dentes sensíveis
FI20060906A0 (fi) Seurantajärjestelmä
FI20085063A (fi) Kuormituksenvalvontalaitteisto
FI20075968A0 (fi) Menetelmä immunomodulaattorihoitojen tehokkuuden tarkkailemiseksi
FI20105103A (fi) Laitteisto pintalietteen poistoon
FI20065514A0 (fi) Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi
FI20080525A (fi) Menetelmä ja laite pyörätuolin liikuttamiseksi
BRPI0820421A2 (pt) Monitoração de vibradores independentes
FI20075751A0 (fi) Sivun monitorointi
FI20070886A0 (fi) Menetelmä korroosion estämiseksi
FI20061110A0 (fi) Kunnonvalvontamenetelmä
FI20095881A0 (fi) Menetelmä ja laitteisto rehupaalien käsittelemiseksi
FI20070310A (fi) Ajanvalvontasovellus

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHT

Free format text: HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMä

Owner name: KOLHO

Free format text: KOLHO

Owner name: VAARALA

Free format text: VAARALA

FD Application lapsed